EN
HI
Summary
As of 15 Sep, 2026, Hester Biosciences stock price is ₹2227. During the trading session, the stock has moved between an intraday low of ₹2212.40 and an intraday high of ₹2299.00. Over the last 52 weeks, Hester Biosciences has traded between ₹1239.30 and ₹2683.60.
The stock has recorded a trading volume of 1,496 shares,. Its Average Traded Price (ATP) is ₹2246.98, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2227.00.
Hester Biosciences has an upper circuit limit of ₹2717.80 and a lower circuit limit of ₹1812.00. The total value traded stands at ₹33.61 L, and the delivery percentage for the day is 44.75%.
The stock is currently traded with a market lot size of 1. Hester Biosciences also offers a dividend yield of 0.48%.
Hester Biosciences Share Price Chart
Hester Biosciences Share Key Metrics
Volume
1496.00
Market Cap
1926.72 CR
LTQ@LTP
1@2227.00
ATP
2246.98
Var Margin
21.99 %
Circuit Range
1812-2717.8
Delivery %
44.75 %
Value
33.61 L
ASM/GSM
No
Market Lot
1
Hester Biosciences Fundamentals
P/E Ratio
14.31
P/B Ratio
4.28
Div. Yield
0.48
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Hester Biosciences Resistance and Support
Pivot 2267.37
Resistance
First Resistance
2296.44
Second Resistance
2327.97
Third Resistance
2357.04
Support
First Support
2235.84
Second Support
2206.77
Third Support
2175.24
Hester Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 15 2026 | 2271 | 2227 | -1.67% | 2299 | 2212.4 |
| Fri Sep 11 2026 | 2275 | 2264.89 | -0.62% | 2298.89 | 2238.3 |
| Thu Sep 10 2026 | 2323 | 2279 | -1.88% | 2343.89 | 2267.5 |
Hester Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-02 | Quarterly Results |
Hester Biosciences News
Hester Biosciences Ltd - 524669 - Shareholders' Approval For Reclassification From 'Promoter And Promoter Group' Category To 'Public' Category Shareholders
Hester Biosciences shareholders approved the reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from the Promoter Group to the Public category. This reclassification affects a combined 9.45% of the company's paid-up share capital.
Sep 04 2026 13:30:36
Hester Biosciences Ltd - 524669 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Hester Biosciences shareholders approved the reclassification of promoter group members to public shareholders with 99.99% votes in favor. This reclassification enhances public shareholding and market accessibility.
Sep 04 2026 10:30:26
Read More
Hester Biosciences Management
| Name | Position |
|---|---|
| Bhupendra Gandhi | Chairman |
| Rajiv Gandhi | Managing Director & Chief Executive Officer |
Hester Biosciences Similar Stocks
Beta Drugs Ltd.
2179.70
61.20 (2.89%)
Windlas Biotech Ltd.
1118.50
-10.75 (0.95%)
Fredun Pharmaceuticals Ltd.
1370.00
-42.20 (2.99%)
Sai Parenteral's Ltd.
509.90
-13.45 (2.57%)
Venus Remedies Ltd.
1555.00
-61.30 (3.79%)
Syncom Formulations (India) Ltd.
18.99
-0.47 (2.42%)
Krsnaa Diagnostics Ltd.
542.80
-7.25 (1.32%)
Q-Line Biotech Ltd.
686.95
-39.25 (5.40%)
Suraksha Diagnostic Ltd.
325.30
1.55 (0.48%)
NGL Fine-Chem Ltd.
2612.10
-45.10 (1.70%)
Hester Biosciences FAQs
The Buying Price of Hester Biosciences share is 2227 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Hester Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Hester Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Hester Biosciences shares is 14.31. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Hester Biosciences shares is 4.28. Useful to assess the stock's value relative to its book value.
To assess Hester Biosciences’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Hester Biosciences is 1926.72 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Hester Biosciences share price is 2683.60 & 1239.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Hester Biosciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in HESTERBIO
